<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">350953</id>
  <title nil="true"/>
  <common-name>(2-chlorophenyl)methyl-[3-[[2-[3-[(2-chlorophenyl)methyl-diethylazaniumyl]propylamino]-2-oxoacetyl]amino]propyl]-diethylazanium</common-name>
  <description>(2-chlorophenyl)methyl-[3-[[2-[3-[(2-chlorophenyl)methyl-diethylazaniumyl]propylamino]-2-oxoacetyl]amino]propyl]-diethylazanium has the chemical formula C30H46Cl2N4O2+2. With an average molecular weight of 565.60 g/mol, (2-chlorophenyl)methyl-[3-[[2-[3-[(2-chlorophenyl)methyl-diethylazaniumyl]propylamino]-2-oxoacetyl]amino]propyl]-diethylazanium is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>9043</pubchem-id>
  <chemical-formula>C30H46Cl2N4O2+2</chemical-formula>
  <weight>565.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T16:21:00Z</created-at>
  <updated-at type="dateTime">2026-08-31T16:21:00Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC[N+](CC)(CCCNC(=O)C(=O)NCCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC2=CC=CC=C2Cl</moldb-smiles>
  <moldb-formula>C30H46Cl2N4O2+2</moldb-formula>
  <moldb-inchi>InChI=1S/C30H44Cl2N4O2/c1-5-35(6-2,23-25-15-9-11-17-27(25)31)21-13-19-33-29(37)30(38)34-20-14-22-36(7-3,8-4)24-26-16-10-12-18-28(26)32/h9-12,15-18H,5-8,13-14,19-24H2,1-4H3/p+2</moldb-inchi>
  <moldb-inchikey>PILWTEPAUNDRNJ-UHFFFAOYSA-P</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">564.2997821</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.8</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM346846</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>(2-chlorophenyl)methyl-[3-[[2-[3-[(2-chlorophenyl)methyl-diethylazaniumyl]propylamino]-2-oxoacetyl]amino]propyl]-diethylazanium</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organic acids and derivatives</superklass>
  <klass>Carboxylic acids and derivatives</klass>
  <subklass>Amino acids, peptides, and analogues</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0301257</sync-id>
  <structure-inchikey>PILWTEPAUNDRNJ-UHFFFAOYSA-P</structure-inchikey>
  <structure-fingerprint>800000000c0000000000000000000400000000000000000000000300040000000000000200000000000a100000000000000000000000000000000000440000000000000000080020001000000000000000000000000000000000010000000000000000000000000040000000000000020000000000000000000040000000800000000000000080000000000100200000000000000000000000000000000004000000080000000000010000000000000000004000040000000000000000040000000000000000000010000000000000000200000000000000000000000000000048000000010400000000000000000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAJwAAAIABBgBgAAAAAQMGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:48:55Z</structure-indexed-at>
</compound>
